standard serum for the measurements of the concentration of a,-Protease inhibitors (inhibiting trypsin, chymotrypsin, and elastase) were demonstrated in human milk from birth to 4 months after delivery. No pepsin inhibitor was found. The protease inhibitors were localized in the al-region-inhibiting trypsin, chymotrypsin, and elastase-and in a more cathodal region-inhibiting chymotrypsin-in agarose gel electrophoresis of human milk. alantitrypsin and antichymotrypsin were demonstrated by crossed immunoelectrophoresis. Electroimmunoassay showed the concentration of a,-antitrypsin in 1st day milk to be 109% and the concentration of antichymotrypsin was 116% of that of adult serum. The concentrations d&;eased during the 1st wk; from 1 wk to 4 months they were 1.6% for a,-antitrypsin and 3.84% for antichymotrypsin of those of adult serum. One ml of human milk from the first 3 days inhibits, by enzymatic methods, 0-150 pg (mean value, 70 pg) trypsin. Milk from 1 week after delivery and later inhibits 0-65 pg (mean value, 38 pg) trypsin per ml.
Trypsin inhibitor in human and bovine colostrum was demonstrated in 1951 by Laskowski & Laskowski (22) . The bovine colostral trypsin inhibitor was later isolated and characterized, and isoinhibitors have been demonstrated (2, 9, 10, 19, 27) . Trypsin inhibitors and isoinhibitors were also demonstrated in wlostrum from the pig (5, 6, 8, 20, 21) and from the rat (7, 3 1) . The general opinion is that the trypsin protease inhibitors in colostrum from these species play a role in the intestinal absorption of proteins, especially of immunoglobulins in the newborn animal (3) .
Few studies have dealt with the trypsin inhibitors in human milk (2, 16, 17) . Data covering the occurrence, amounts, and properties of protease inhibitors in human milk from various periods of the lactation are incomplete. The physiologic role of the inhibitors in human milk is obscure.
The present study reports the occurrence, electrophoretic properties, and amounts of some protease inhibitors in human milk from birth to 4 months after delivery.
MATERIALS
Human milk was collected from healthy mothers on the Ist, 2nd. and 3rd day, and between 1 wk and 4 months after delivery. The samples were either analyzed directly or stored at -20°C until analysis. Urine and serum samples from infants were stored at -20°C until analysis. Trypsin, chymotrypsin, elastase, and pepsin inhibitors were detected by means of agarose gel diffusion in combination with agarose gel electrophoresis (4) . A microscope slide with a gel containing 2.25% agarose and 0.1% casein was immersed for 45 min in buffer (for trypsin and chymotrypsin 0.05 M trisbuffer, pH 7.9 containing 0.22 M CaC12, for pepsin acetate-hydrochloric acid buffer, pH 2). For elastase, the gel contained 0.8% agarose and 0.6% elastin in 0.1 M trisbuffer pH 8.6. Enzyme solution (trypsin 0.05 mg/ml of 0.001 M HC1, chymotrypsin 0.1 mg/ml, elastase 0.05 mg/ml, and pepsin 0.1 mg/ml) was poured into a central trough in the gel. An agarose gel electrophoretic strip of, e.g., human milk was immediately laid on the agarose-substrate gel on each side of the trough. ~f i e r incubation for 4 hr (trypsin; chymotrypsin, pepsin) and 18 hr (elastase) at 37°C. thdmlide was immersed in 2% acetic acid for I hr, dried, and the caseincontaining slides were stained with amido black. Undigested casein is stained dark blue (black in photos), whereas digested casein gives no stain (see Fig. 1 ). Elastolytic activity is seen without staining as a clear zone in the densely opalescent elastin-agarose.
ELECTROPHORESIS A N D IMMUNOELECTROPHORESIS
Agarose gel electrophoresis (I 8), crossed immunoelectrophoresis (13, 23) , and electroimmunoassay (24, 25) were performed with 0.075 M barbital-sodium barbitaibuffer, pH 8.6, containing 0.002 M calcium lactate.
QUANTITATIVE DETERMINATION OF TRYPSIN-INHIBITING ACTIVITY
The inhibiting capacity of centrifuged (defatted) human milk against bovine trypsin was determined using BAPNA as substrate (6, 12) . Figure 1 shows the trypsin inhibiting activity in porcine colostrum, in human milk from the 2nd day, and in serum and urine from the 2-day-old infant. The trypsin inhibitors have different electrophoretic mobility in the various samples. In the porcine colostrum, they are localized in the yregion; in human milk and in the urine of the infant, in the al-region; and in the infant's serum in the a,-and a2-regions. All serum and urine samples from a further 15 infants, 0-to 3-days-old, showed a trypsin inhibiting capacity with the same electrophoretic mobility as in Figure I , irrespective of whether the samples were taken before or after the infant's first breast meal.
RESULTS

DEMONSTRATION OF PROTEASE INHIBITORS
Twenty samples of human milk were heated for 10 min in boiling water: trypsin inhibiting capacity disappeared in 14 samples and diminished in 6. There was no difference in trypsin inhibiting capacity between centrifuged (defatted) and noncentrifuged milk.
The electrophoretic mobility of chymotrypsin and elastase inhibitors was similar to that of the trypsin inhibitors, except that 5 of 10 samples from the first 2 days, another inhibiting activity against chymotrypsin was detected, localized cathodally to the other. Milk from day 3 or later had this inhibiting activity in 3 of 18 samples. Pepsin inhibitor could not be demonstrated. Table 1 summarizes the results. Figure 2 shows the crossed immunoelectrophoresis of human milk from the lst, 2nd, and 3rd day after delivery against antihuman al-antitrypsin and antihuman antichymotryps&. The concentrations of a,-antitrypsin and antichymotrypsin decrease during these 3 days. The protein band in electrophoresis corresponding to al-antitrypsin is distinct in the samples from the 1st day, faint from the 2nd, and hardly visible from the 3rd day. The crossed immunoelectrophoresis showed in some cases an asymmetric precipitate of al-antitrypsin with an irregular cathodal slope indicating microheterogeneity. Two components of antichymotrypsin were found, one minor in the an-region and one major with a slower electrophoretic mobility. Figure 3 shows the contents of a]-antitrypsin and antichymotrypsin in human milk at varying times after delivery, determined with the electroimmunoassay technique. The concentration is related to that in human serum. During the first 3 days the amount of antichymotrypsin was higher than that of al-antitrypsin.
IMMUNOELECTROPHORESIS STUDIES
TRYPSIN INHIBITING CAPACITY OF HUMAN MILK
Trypsin, 0.95 g, is inhibited to 90-95% by a]-antitrypsin/liter human plasma (1 I). Thus, from the results in Figure 3 , a,-antitrypsin in I ml of human milk from the various times after birth theoretically should inhibit about 95,45,40, and 15 pg of trypsin, respectively. The spectrophotometric method with BAPNA as substrate produced the following values: I ml of milk from nine mothers from the first 3 days inhibited: 150, 30, and 30 pg (0-24 hr); 95 and 0 pg (24-48 hr); 140, 55, 55, and 0 pg (48-72 hr) of bovine trypsin (mean value, 70 pg). During the later part of the lactation period (I wk to 4 months), I ml inhibited 0-65 pg trypsin (mean vaiue: 38 pg, n = 9).
DISCUSSION
The dominant protease inhibitors in plasma against trypsin, chymotrypsin, and elastase are a,-antitrypsin and a?-macroglobulin. Antichymotrypsin in plasma is of minor importance as a protease inhibitor (26, 29) .
This study has shown that human milk from birth to 4 months after delivery inhibits the proteolytic activity of trypsin, chymotrypsin, and elastase. The inhibitor against these enzymes is electrophoretically localized in the a1-region and also in a more cathodal region against chymotrypsin, in contrast to that in porcine colostrum where it is found in the y-region (5) . No inhibiting activity against trypsin and elastase could be detected in the azregion in the electrophoresis of human milk. This agrees with reports that an-macroglobulin is not found in human milk (14, 15) . In serum from infants, trypsin inhibiting activity was detected in the al-and a*-region, but in urine in the al-region only. The pattern was the same irrespective of whether the samples were taken before or after the infants' first breast meal. However, as we have no quantitative data of the trypsin inhibitors in urine, it remains to be shown if intestinal absorption and urinary excretion of milk trypsin inhibitors as found in the newborn pig (1, 8) occurs in the newborn infant. Fig. 3 . Content o f a,-antitrypsin a n d antichymotrypsin i n h u m a n milk from various times after delivery in relation t o the content in adult h u m a n serum. (100% means 1.35 g a,-antitrypsin/liter a n d 0.5 g antichymotrypsin/liter.) %, m e a n value rt_ SEM. al-antitrypsin was previously found in human milk (15) . In the present study, crossed immunoelectrophoresis demonstrated alantitrypsin in the same region where the protease inhibiting activity was found. This agrees with the findings of Barkholt Pedersen et al. (2) . Using gel chromatography, they found only one peak of antitrypsin activity in human colostrum. This peak had an elution volume close to that of serum albumin. They also found that the trypsin inhibitor, like al-antitrypsin, was destroyed by trichloroacetic acid and had a low stability below pH 5.5.
PROTEASE INHIBITORS IN HUMAN MILK
1 TIME AFTER DELIVERY
Crossed immunoelectrophoresis demonstrated two components of antichymotrypsin in human milk. The minor component had the same mobility as antichymotrypsin in plasma, whereas the major one had a slower mobility. Possibly, it represents a complex formation between a protease and antichymotrypsin.
In 1st-day milk, the concentration of antichyrnotrypsin was the same as in adult serum; and in contrast to serum the absolute amounts were higher than those of al-antitrypsin. The amount of antichymotrypsin decreased and was somewhat lower than that of al-antitrypsin at 1 week or later after delivery. In this context, it is of interest to note that in pulmonary secretions the relative concentration of antichymotrypsin is higher than for al-antitrypsin (28, 30) .
The trypsin inhibiting capacity of human milk is much lower than that of porcine and bovine colostrum. One ml of the 1st-day colostrum from the pig inhibits about 2000 pg and from the cow about 600 pg of trypsin, whereas the corresponding figure for human milk from the first 3 days is 20-60 pg (2, 17, 21, 22) . Laskowski and Laskowski (22) could not detect any inhibitor on the 5th day, and Hyanek et al. (17) reported low values (0-20 pg) on the 6th day. The present study obtained somewhat higher values. The differences, which are small, could well be explained by the use of different methods. For comparison, Zoppi et al. (32) reported a trypsin content in duodenal juice at birth of about 120 g / m l (during 50 min after pancreozymin and secretin); 24 hr after first feeding about 75 pg/ml; and at I week about 200 pg/ml. Similar to Hyanek et al. (17) , we could detect trypsin inhibitory activity in 50% of the milk samples from the 1st day, in 75% from the 2nd, and in 12 of 13 from the 3rd day. All samples from 1 week after delivery and later showed a trypsin inhibitory activity. This inhibiting activity was exerted by a1-antitrypsin. Chymotrypsin inhibiting activity exerted by antichyrnotrypsin was observed in half of the milk samples from the first 2 days, and only occasionally in milk from day 3 or later.
al-antitrypsin and antichymotrypsin were at the same time immunochemically present in "normal" amounts. The reason for this discrepancy is obscure, but various degrees of complex formation between the inhibitors and proteolytic enzymes occurring in human milk might be responsible.
The decrease in the concentration of al-antitrypsin and antichymotrypsin during the 1st week coincides with the decrease in the concentration of other proteins in human milk. However, the amount of the milk increases; therefore, the total amount of alantitrypsin per meal received by the infant during the whole lactation period remains about the same.
From this and from previous studies (2), it can be concluded that the demonstrated protease inhibitory capacity of human milk can be mainly ascribed to the al-antitrypsin. The physiologic role of the protease inhibitors in human milk is obscure. One role might be to inhibit proteolytic enzymes liberated from the leucocytes occurring in human milk. Possibly, the protease inhibitors might contribute to the local immunity in the lumen of the gut and might favor the enhanced intestinal absorption of macromolecules (proteins) in early infancy.
